Outcome of Full Pulpotomy Using Calcium Silicate Based Materials (pulpotomy)

September 15, 2021 updated by: Jordan University of Science and Technology

Outcome of Full Pulpotomy in Permanent Teeth With Carious Pulp Exposure, a Randomized Clinical Trial

Permanent teeth with carious pulp exposure and indicated for full pulpotomy will be treated using three different materials using aseptic technique and will be subsequently followed up clinically and radiographically at 6 months, 1 year and yearly up to 5 years.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

  • The target sample size is 150 patients medically fit, having vital teeth with carious pulp exposure and complaining of pain.
  • The patients tooth will receive full pulpotomy under aseptic conditions and it will be randomly assigned to one of 3 calcium silicate based materials namely, (Mineral trioxide Aggregate (MTA), Biodentine, and Bioceramic for capping the full pulpotomy followed by resin composite restoration.
  • Follow up for pain levels will be done during the first week.
  • clinical and radiographic examination will be done at 6 months, 1 year and yearly up to 5 years.
  • Success of the procedure includes absence of clinical signs and symptoms, with absence of pathology in the root and periapex on periapical radiographs.
  • The 3 materials will be compared in terms of clinical and radiographic outcomes.
  • demographic data of the three groups will be also compared
  • predictive factors of success will be also analyzed
  • tooth color changes will be also measured using vita easy shade and will compared between the groups at 6 months and 1 year.

Study Type

Interventional

Enrollment (Anticipated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • IRbid, Jordan, 21110
        • Dental teaching centre Faculty Of Dentistry
      • Irbid, Jordan, 22110
        • Jordan University of Science and Technology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 70 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Mature permanent tooth with carious lesion exposing the pulp,
  • Positive response to cold test
  • Clinical Diagnosis of reversible or irreversible pulpitis
  • Restorable tooth by direct restoration or crown
  • Healthy patient

Exclusion Criteria:

  • Non vital teeth
  • Teeth without pulp exposure
  • Inability to achieve hemostasis within 10 min after pulpotomy
  • Non restorable teeth or teeth that require post and core restoration

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: MTA pulpotomy
Tooth will receive MTA & resin composite restoration
Cutting the coronal portion of the pulp to the level of canal orifices and applying the dressing and restoration
Other Names:
  • Biodentine pulpotomy and Bioceramic pulpotomy
Active Comparator: Biodentine pulpotomy
Tooth will receive Biodentine & resin composite restoration
Cutting the coronal portion of the pulp to the level of canal orifices and applying the dressing and restoration
Other Names:
  • Biodentine pulpotomy and Bioceramic pulpotomy
Active Comparator: Bioceramic pulpotomy
Tooth will receive Bioceramic & resin composite restoration
Cutting the coronal portion of the pulp to the level of canal orifices and applying the dressing and restoration
Other Names:
  • Biodentine pulpotomy and Bioceramic pulpotomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Degree of pain relief after treatment compared to preoperative pain level
Time Frame: 1 week
Absence of symptoms or significant pain reduction within the first week after treatment as measured on a numerical scale from 0 to 10 where zero means no pain and 10 is the most sever pain. Visual analogue scale will be also used.
1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiographic normalcy
Time Frame: 1 year and yearly up to 5 years
Absence of pathology in the root and the bone surrounding the apex
1 year and yearly up to 5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2017

Primary Completion (Actual)

May 2, 2018

Study Completion (Anticipated)

May 2, 2023

Study Registration Dates

First Submitted

April 9, 2020

First Submitted That Met QC Criteria

April 12, 2020

First Posted (Actual)

April 14, 2020

Study Record Updates

Last Update Posted (Actual)

September 22, 2021

Last Update Submitted That Met QC Criteria

September 15, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Detailed participants data will be released within the publications resulting from the trial with reference to the registration number of the study. If further details are required the principal investigator. can be contacted via email.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carious Teeth

Clinical Trials on MTA pulpotomy

3
Subscribe